This inventor holds 2 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: The Brigham and Women's Hospital, Inc., Massachusetts Institute of Technology, The General Hospital Corporation. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 1,429 
1 out of 8,594 
1 out of 3,076 
Years Active: 2019-2026
Title: Oleg Butovsky: Innovator in Neurodegenerative Disorder Treatments
Introduction
Oleg Butovsky is a prominent inventor based in Boston, MA (US), known for his significant contributions to the field of neurodegenerative disorders. His innovative work focuses on developing methods to treat conditions such as Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis (MS).
Latest Patents
Oleg Butovsky holds a patent titled "Micrornas in neurodegenerative disorders." This patent outlines methods for treating neurodegenerative disorders by administering at least one inhibitory nucleic acid that decreases the level or activity of microRNA hsa-miR-155. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Oleg has worked with esteemed institutions, including Brigham and Women's Hospital and The General Hospital Corporation. His work in these organizations has allowed him to collaborate with leading experts in the field, further enhancing his research and innovation.
Collaborations
Oleg Butovsky has collaborated with notable colleagues such as Howard L. Weiner and Merit Cudkowicz. These partnerships have contributed to the advancement of research in neurodegenerative disorders and have helped in the development of effective treatment methods.
Conclusion
Oleg Butovsky's contributions to the field of neurodegenerative disorders through his innovative patent and collaborations with leading experts highlight his dedication to improving patient outcomes. His work continues to inspire advancements in medical research and treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile